Advances in the mechanism of action and clinical studies of the novel antiepileptic drug brivaracetam
Epilepsy is one of the common diseases of the nervous system,which is characterized by repeated epilep-tic seizures caused by abnormal discharge of brain neurons.Brivaracetam is an analogue of the third-generation antiepilep-tic drug levetiracetam and exerts a therapeutic effect by binding to synaptic vesicular protein 2A.This article reviews the disease of epilepsy and the mechanism of action,pharmacokinetic characteristics,clinical efficacy,safety,and adverse reactions of brivaracetam in epilepsy,in order to provide a better choice of drugs for the treatment of epilepsy.
EpilepsyBrivaracetamAntiepileptic drugsSynaptic vesicular protein
国家科技期刊平台
NSTL
万方数据
